Skip to content

Press

Portfolio-Media Coverage
Nido Biosciences Secures $109 Million to Advance Precision Medicines for Neurological Diseases
May 15, 2023 May 15, 2023 Silicon Valley Journals
Portfolio-Media Coverage
Nido Biosciences raises $109M to drug novel targets in neurological disease
May 15, 2023 May 15, 2023 Bioworld
Portfolio-Media Coverage
Nido Bio – Five years after founding, neuroscience startup emerges with $109M
May 15, 2023 May 15, 2023 BizJournals
Portfolio-Media Coverage
Nido debuts with $109M for its precision approach to brain drugs
May 15, 2023 May 15, 2023 Biopharma Dive
Portfolio-Media Coverage
From 5AM’s nest, neuroscience startup Nido Biosciences launches with $109M and PhI underway
May 15, 2023 May 15, 2023 Endpoints
Portfolio-Media Coverage
Ensoma – GENE EDITING: Overhyped or Unstoppable Tide?
May 9, 2023 May 9, 2023 Evaluate Vantage
Portfolio-Media Coverage
Gene Editing Therapies Delivered In Vivo: Ensoma’s Emile Nuwaysir on The Long Run
April 24, 2023 Apr 24, 2023 The Timmerman Report
Portfolio-Press Releases
Recode Therapeutics Appoints John G. Matthews, MBBS, MRCP, Ph.D., as Senior Vice President, Clinical Development
April 17, 2023 Apr 17, 2023
Portfolio-Media Coverage
Nido Biosciences divulges new SARMs
February 10, 2023 Feb 10, 2023 Bioworld
Portfolio-Press Releases
Ensoma Announces Closing of Twelve Bio Acquisition
February 9, 2023 Feb 9, 2023